Key facts

Active Substance
Single strain of non-genetically modified Prevotella histicola (EDP1815)
Therapeutic area
Dermatology
Decision number
P/0008/2022
PIP number
EMEA-002933-PIP01-20
Pharmaceutical form(s)
  • Age-appropriate oral solid dosage form
  • Capsule (hard)
Condition(s) / indication(s)
Treatment of psoriasis
Route(s) of administration
Oral use
Contact for public enquiries

Evelo Biosciences, Inc.

info@evelobio.com

 +1 6175770300

Decision type
P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)
Decision date

Decision

How useful do you find this page?